AI-powered pathology presents the NHS with a unique opportunity to enhance cancer detection. Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system.
Here, we examine the role of the Japanese Cancer Association (JCA) when it comes to the field of cancer research in Japan, including basic, clinical and translational.
During Men’s Health Week (10-16 June 2019) Breast Cancer Haven aims to raise awareness of breast cancer amongst the male population and remind the public that the charity’s services are available to anyone affected by the disease.
False positives in cancer diagnosis cost NHS millions each year and cause huge anxiety across the nation, Wesley Baker, CEO of ANCON Medical discusses the impact of outdated cancer diagnosis.
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group gives an overall perspective on the challenges and concerns around acute promyelocytic leukaemia (APL), a type of blood cancer.
Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.
The European Elections 2019 Manifesto for the Paediatric Oncology & Haematology community has been launched, and it prioritises beating childhood cancer to aim for zero deaths.
